Asahi Intecc Co., Ltd. (TYO:7747)
3,061.00
-1.00 (-0.03%)
At close: Dec 5, 2025
Asahi Intecc Revenue
Asahi Intecc had revenue of 36.06B JPY in the quarter ending September 30, 2025, with 15.63% growth. This brings the company's revenue in the last twelve months to 124.90B, up 13.53% year-over-year. In the fiscal year ending June 30, 2025, Asahi Intecc had annual revenue of 120.03B with 11.60% growth.
Revenue (ttm)
124.90B
Revenue Growth
+13.53%
P/S Ratio
6.50
Revenue / Employee
13.18M
Employees
9,473
Market Cap
812.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 120.03B | 12.48B | 11.60% |
| Jun 30, 2024 | 107.55B | 17.45B | 19.36% |
| Jun 30, 2023 | 90.10B | 12.35B | 15.89% |
| Jun 30, 2022 | 77.75B | 16.24B | 26.41% |
| Jun 30, 2021 | 61.51B | 4.96B | 8.77% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |
Asahi Intecc News
- 22 days ago - Asahi Intecc Backs Positive Outlook For FY After Higher Q1 Profit - Update - Nasdaq